GradedCalls Analysts
Loading the ledger…
Public news sources, graded against Yahoo Finance adjusted closes (adjusted for splits and dividends) through 16 Oct 2026. Not investment advice.
GradedCallsGradedCallsGradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
Johnson & Johnson · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 90D
21.2/100Average of active call grades
GC score3/10GC 1→GC 10
GC 1–4. Under 40 is WEAK on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
| Analyst | Firm | N | Hit | Overall factor/100 · GC 1–10 |
|---|---|---|---|---|
| Jayson Bedford | Raymond James | 1 | 0% | 30/1004/10 |
| Shagun Singh | RBC | 1 | 0% | 18.6/1002/10 |
| Michael Nedelcovych | TD Cowen | 1 | 0% | 14.9 |
These calls count toward the overall factor once the horizon has a price. An open window is listed and is not in the average yet.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 Supersedes Supersedes prior call on Oct 14, 2026 (within 90 days). Prior call | Larry BiegelsenWells Fargo | Target raise Desk rating stays Overweight | Buy | — | — | |||
| Oct 15, 2026 |
3
In this factor
Superseded
5
Visible, not scored
Hit rate
0%
Active calls only
If followed
+2.0%
Active directional calls
Active calls on JNJ were a full hit 0% of the time. Hit rate is not the rank.
| Terence FlynnMorgan Stanley |
| Target cut Desk rating stays Overweight |
| Buy |
| — |
| — |
| Oct 14, 2026 | David RisingerLeerink | Target cut Desk rating stays Outperform | Buy | — | — |
| Oct 14, 2026 | Trung HuynhRBC | Target cut Desk rating stays Outperform | Buy | — | — |
| Oct 7, 2026 Supersedes Supersedes prior call on Aug 6, 2026 (within 90 days). Prior call | Vamil DivanGuggenheim | Reiterate Buy Desk rating stays Buy | Buy | — | — |
| Oct 5, 2026 | Joanne WuenschCiti | Target raise Desk rating stays Buy | Buy | — | — |
| Sep 10, 2026 | Rajesh KumarHSBC | Target raise Desk rating stays Buy | Buy | — | — |
| Sep 2, 2026 | Michael YeeUBS | Target raise Desk rating stays Buy | Buy | — | — |
| Jul 16, 2026 Supersedes Supersedes prior call on Jul 13, 2026 (within 90 days). Prior call | Shagun SinghRBC | Reiterate Outperform Desk rating stays Outperform | Buy | $253.91 | +2.1% | Miss |
| Jul 16, 2026 | Jayson BedfordRaymond James | Target raise Desk rating stays Outperform | Buy | $253.91 | +2.1% | Miss |
| Jul 13, 2026 | Michael NedelcovychTD Cowen | Target raise Desk rating stays Buy | Buy | $261.44 | +1.9% | Miss |